Did you know? You can suggest edits to improve this peptide information.
Overview
What is Oxytocin?
Oxytocin is a nine-amino-acid peptide hormone and neuropeptide naturally produced in the hypothalamus and released by the posterior pituitary. Known as the "love hormone" or "bonding hormone," it plays fundamental roles in social bonding, trust, empathy, sexual reproduction, childbirth, and lactation. Synthetic oxytocin (Pitocin/Syntocinon) is FDA-approved for labor induction and postpartum hemorrhage control, while intranasal formulations are being researched for autism spectrum disorders, anxiety, depression, PTSD, chronic pain, and sexual dysfunction.
Key Benefits
FDA-approved for labor induction and postpartum hemorrhage control, precise dosing via IV infusion, immediate onset, well-established safety profile in obstetric settings
Mechanism of Action
Binds to oxytocin receptors (OXTR) on uterine smooth muscle cells, triggering calcium influx and myometrial contractions. Also stimulates prostaglandin release to enhance uterine sensitivity.
Molecular Information
Weight
1,007.19 Da
Length
9 amino acids
Type
Cyclic nonapeptide
Amino Acid Sequence:
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2
* Disulfide bridge between Cys1-Cys6 forming cyclic structure, C-terminal amidation
Pharmacokinetics
Research Indications
Labor Induction
FDA-approved for initiation or augmentation of uterine contractions when vaginal delivery is medically indicated
Postpartum Hemorrhage Prevention
FDA-approved for control of postpartum bleeding through uterine contraction stimulation during third stage of labor
Incomplete Abortion Management
Adjunctive therapy for management of incomplete or inevitable abortion in second trimester
Research Protocols
Disclaimer
These are commonly discussed research protocols and not medical advice. Consult a healthcare provider before use.
Timing
Injectable oxytocin is used in clinical settings for labor and delivery. Onset is immediate (IV) to 3-5 minutes (IM). Effects are short-lived requiring continuous infusion for labor.
Peptide Interactions
How to Reconstitute
Important
Use sterile water or sterile saline only. Benzyl alcohol (in BAC water) degrades oxytocin. For multi-dose, refrigerate and use within 48-72 hours, or freeze single-dose aliquots.
This is a hospital/clinical procedure performed by healthcare professionals
Dilute oxytocin in compatible IV solution per facility protocol
Typical dilution: 10 units in 1000mL = 10 mU/mL
Use infusion pump for precise rate control
Monitor uterine contractions and fetal heart rate continuously
Adjust rate based on clinical response and safety parameters
Have emergency medications available (terbutaline for tocolysis)
Quality Indicators
FDA-approved pharmaceutical product
Use only FDA-approved oxytocin injection (Pitocin) from licensed pharmacies
Clear, colorless solution
Oxytocin injection should be clear without particles or discoloration
Proper packaging and labeling
Verify lot number, expiration date, and concentration (10 units/mL typical)
Cloudy or discolored solution
Do not use if solution appears cloudy, contains particles, or is discolored
Requires clinical setting
Injectable oxytocin should only be administered in clinical settings with proper monitoring
What to Expect
- Used exclusively in clinical/hospital settings
- Immediate onset of uterine contractions (IV)
- Requires continuous monitoring of contractions and fetal heart rate
- Effects diminish rapidly after discontinuation (short half-life ~3-5 min)
- May cause transient blood pressure changes
- Common side effects: nausea, vomiting, headache
Side Effects & Safety
- Must be administered only by qualified healthcare professionals
- Requires continuous electronic fetal monitoring during labor
- Uterine hyperstimulation is the primary concern - can cause fetal distress
- Contraindicated in certain obstetric conditions (see prescribing information)
- Water intoxication risk with high doses or prolonged infusion
- Have tocolytic agents available for uterine hyperstimulation
References
Intranasal Oxytocin for Obesity (2024)
Treatment did not result in weight loss but showed significant reduction in caloric intake at test meals and improvement in mental health-related quality of life. No serious adverse events.
View Study (opens in new tab) →Oxytocin Effects on Social Cognition in Schizophrenia (2023)
While no significant advantage over placebo on primary social cognition outcomes, oxytocin showed modest improvement in social functioning and within-group reduction in negative symptoms.
View Study (opens in new tab) →Intranasal Oxytocin in Autism Spectrum Disorder (2021)
Large randomized controlled trial found intranasal oxytocin did not significantly improve social functioning in children and adolescents with ASD compared to placebo, highlighting need for better patient selection and dosing strategies.
View Study (opens in new tab) →Quick Start Guide
Community Poll
Question 1 of 10
What is your experience with this compound?
Poll Results
Loading results...
Community Insights
Self-reported by PepPedia users. Not clinical evidence. Health changes reflect all users, including those taking multiple compounds.
Was this helpful?
Your feedback helps us improve PepPedia